English (English)
Deutsch (German)
Čeština (Czech)
Italiano (Italian)
Hrvatski (Croatian)
Română (Romanian)
български език (Bulgarian)
Magyar (Hungarian)
Español (Spanish)
Français (French)
Nederlands (Dutch)
Polski (Polish)
Slovenčina (Slovak)
The world of veterinary medicine is experiencing a silent revolution with the growing interest in cannabinoids derived from cannabis as collectible genetic material. Recent research has begun to explore the therapeutic potential of CBD in domestic animals, particularly in dogs and cats suffering from various conditions.
It is essential to understand that only specifically formulated and correctly dosed preparations can offer potential benefits for pets, while the inappropriate use of non-specialized products can cause serious health problems for our furry companions.
Scientific Advances in Veterinary CBD
Cornell University has led pioneering research in this field, publishing extraordinarily promising results in the international scientific journal "Frontiers of Veterinary Science". The study, titled "Pharmacokinetics, Safety, and Clinical Efficacy of Cannabidiol Treatment in Osteoarthritic Dogs", was led by the prestigious Dr. Joseph Wakshlag.
The researchers evaluated the effectiveness of specific CBD products applied to dogs with arthritis, measuring both the safety and efficacy of the treatment. The results showed that more than 80% of the participating dogs experienced a significant reduction in pain, along with notable improvements in their overall mobility.
This research represents an important milestone in understanding how aromatic profiles and the chemical composition of cannabis genetics can translate into therapeutic applications for animals. The terpenes and cannabinoids present in these collectible varieties show properties that go beyond what was initially understood.
Legal and Professional Barriers
Despite the promising results, there is a significant barrier in the veterinary field. Most veterinarians cannot legally recommend or prescribe cannabinoid preparations for pets, regardless of their professional or personal convictions on the matter.
Even in progressive states such as California, considered the mecca of medicinal cannabis, the State Veterinary Board maintains a restrictive position. According to its official statement: "There is no provision in California veterinary law that allows veterinarians to prescribe or recommend in any way medicinal preparations based on cannabis for the treatment of animals."
Dr. Gary Richter of Oakland has worked tirelessly on an online petition called "compassionate care", focused on changing legislation to allow CBD recommendations for dogs and cats in California. His efforts have borne fruit, and legislation has recently been approved that represents a step forward, although much remains to be done.
Emerging Therapeutic Applications
The cannabis genetics rich in CBD are showing therapeutic profiles that go beyond the treatment of arthritis. Researchers have observed potential improvements in various conditions:
- Chronic pain management - The natural analgesic properties of certain cannabinoids
- Reduction of inflammation - Specific anti-inflammatory profiles of some varieties
- Anxiety management - Calming effects associated with specific terpenes
- Gastrointestinal issues - Digestive properties of certain compounds
- Seizures - Anticonvulsant potential of specific cannabinoids
Dr. Richter explains that "almost any cannabis treatment that demonstrates therapeutic potential in humans can probably also be applied in the case of animals". However, he emphasizes that research must continue to fully understand the mechanisms of action and appropriate dosages.
Safety Considerations and Future of Research
The scientific community recognizes that the number and depth of current studies are still not sufficient to state with absolute certainty that substances derived from medicinal cannabis can safely help dogs and cats. Nevertheless, the preliminary results are extraordinarily promising.
Researchers are working to better understand the pharmacokinetics of cannabinoids in animal biological systems. The unique composition of terpenes and cannabinoids in different collectible genetics offers a broad spectrum of therapeutic possibilities that require systematic research.
As Dr. Wakshlag of Cornell mentions: "If my dog ever started suffering from arthritis, I would definitely turn to some cannabis preparation. Not only that, I would consider it as my very first absolute first option". This statement from a leading researcher in the field underscores the potential that scientists see in this area.
The scientific community continues to expand its understanding of how different varieties of collectible seeds, with their unique profiles of aromatic compounds, can contribute to the development of more effective and safer veterinary therapies. The future of this research promises to revolutionize veterinary medicine as we know it.